Skip to main content
Top
Published in:

01-10-2019 | Infliximab | Case report

Infliximab

Infusion related reactions manifested as rash, shortness of breath and chest pain: 2 case reports

Published in: Reactions Weekly | Issue 1/2019

Login to get access

Excerpt

In a retrospective review of patients treated between January 2018 to December 2018, two male patients [ages at the time of reactions onsets not stated] were described, who developed infusion related reactions manifested as rash (1 patient) and shortness of breath with chest pain (1 patient) following administration of infliximab for inflammatory bowel disease. …
Literature
go back to reference Collins K, et al. Monitoring after biological infusions for inflammatory bowel disease: Is it necessary?. Journal of Gastroenterology and Hepatology 34 (Suppl. 2): 142-143, Sep 2019. Available from: URL: http://doi.org/10.1111/jgh.14801 [abstract] - Australia Collins K, et al. Monitoring after biological infusions for inflammatory bowel disease: Is it necessary?. Journal of Gastroenterology and Hepatology 34 (Suppl. 2): 142-143, Sep 2019. Available from: URL: http://​doi.​org/​10.​1111/​jgh.​14801 [abstract] - Australia
Metadata
Title
Infliximab
Infusion related reactions manifested as rash, shortness of breath and chest pain: 2 case reports
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-69962-4